Cairo University Hospitals
Giza, Giza Governorate, 11562, Egypt
NCT Number: NCT06327399
Dexmedetomidine bolus dose may provide similar or less hemodynamic changes (less bradycardia and less hypertension) than infusion dose during induction of anaesthesia and tracheal intubation.
Looking for future studies?
Notify Me18 year–50 year
All sexes
Interventional
Phase 2
Giza, Giza Governorate, 11562, Egypt
Preoperative assessment of all patients undergoing elective surgical procedures under general anaesthesia comprises history taking, clinical examination, laboratory testing (complete blood count, kidney function tests, liver function tests), electrocardiogram, and chest X-ray. The study protocol will be explained to the patients, and their consent will be obtained. The patients will be continuously monitored in the operating room for heart rate, blood pressure, and oxygen saturation (baseline values). Then a 20-gauge cannula will be inserted.
Patients will be randomly assigned into two groups: Group A will receive Dexmedetomidine infusion dose of 1 mcg/kg diluted to 100 ml normal saline infused over 10 minutes and Group B will receive Dexmedetomidine bolus dose of 0.3 mcg/kg diluted to 10 mL normal saline administered intravenously over 60 seconds. Then Patients will be induced with propofol 2mg/kg, followed by atracurium 0.5 mg/kg IV. After 3 minutes, tracheal intubation will be performed with an appropriate size of cuffed tracheal tube and connected to end tidal CO2 monitor. After confirmation of bilateral equal air entry, it is connected to mechanical ventilation using isoflurane 1.2% for maintaining anesthesia and keeping end tidal CO2 between 35-40 mmHg, Ringer's solution at a rate 5ml/kg/hour IV will be infused for fluid maintenance. If heart rate falls below 45 bpm, rescue dose (500 mcg) of atropine will be given. If MAP decreases below 50 mmHg, boluses of 10 mg ephedrine will be given, while escalation of MAP will be treated by boluses of 50 mg propofol.
At the end of surgery, the inhaled gas is off and the patient is reversed with neostigmine 0.05mg/kg and atropine 0.01mg/kg, then extubation is done. The two groups will be observed for changes in hemodynamic parameters i.e. heart rate (HR) and mean arterial blood pressure at preinduction period (baseline), after 1 min from dexmeditomedine taking, after induction, at intubation and 1,3,5 and 10 min after intubation. No intervention will be allowed during these 10 minutes and morphine at a dose 0.1mg/kg will be used as analgesia for surgery after 10 minutes.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
patients will receive Dexmedetomidine infusion dose of 1 mcg/kg over 10 min before induction.
Other names: infusion
patients will receive Dexmedetomidine bolus dose of 0.3 mcg/kg over 60 seconds.
Other names: Bolus
If heart rate falls below 45 bpm, rescue dose (500 mcg) of atropine will be given.
If mean blood pressure decreases below 50 mmHg, boluses of 10 mg ephedrine will be given
Time frame: 1 minute
mean blood pressure measurement (mmhg) during laryngoscopy
Time frame: 1 min after dexmeditomedine, after induction, at intubation and 1,3,5 and 10 min after intubation
Heart rate (bpm), Systolic, Diastolic and Mean arterial blood pressure (mmhg)
Time frame: from start of dexmedetomidine injection before induction till 10 minutes after intubation
Number of events : If heart rate falls below 45 bpm, rescue dose (500 mcg) of atropine will be given.
Kasr El Aini Hospital
Other
Effect of Dexmedetomidine Infusion Dose Versus Rapid Bolus Dose on Hemodynamic Changes During Laryngoscopy and Tracheal Intubation in Adults. A Randomized Comparative Study.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06848764
Blood Loss, Surgical, Dexmedetomidine
Cairo, Egypt
View Trial DetailsNCT06837519
Dexmedetomidine, Infusion
Cairo, Egypt
View Trial DetailsNCT07508202
Dexmedetomidine, Post Operative Analgesia
Islamabad, Federal, Pakistan
View Trial DetailsNCT05950646
Dexmedetomidine, Dyssomnias
Beijing, Beijing Municipality, China
View Trial Details